Blackstone to sell Japan supplement maker Alinamin to MBK for $2.2bn

TOKYO -- Asian investment fund MBK Partners will buy Japan's Alinamin Pharmaceutical, a maker of supplements and nonprescription drugs, from Blackstone Group for an estimated 350 billion yen ($2.2 billion), Nikkei learned Tuesday.